drugset / Trial / NCT02905682
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to demonstrate efficacy of desmopressin ODT against placebo for the treatment of female subjects with nocturia due to nocturnal polyuria, during 12 weeks of treatment.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-09-27
- Completion
- 2017-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 25 ug | Oral |
Indications
No indication recorded.